- Case Report
- Open Access
6q16.3q23.3 duplication associated with Prader-Willi-like syndrome
Molecular Cytogenetics volume 8, Article number: 42 (2015)
Prader-Willi syndrome (PWS) is characterized by hypotonia, delayed neuropsychomotor development, overeating, obesity and mental deficiency. This phenotype is encountered in other conditions, defining Prader-Willi-like syndrome (PWLS).
We report a 14-year-old boy with a complex small supernumerary marker chromosome (sSMC) associated with PWLS. The propositus presents clinical features commonly found in patients with PWLS, including growth hormone deficit. Banding karyotype analysis and fluorescence in situ hybridization (FISH) revealed a marker derived from chromosome 6 and a neocentromere as suspected, but array-CGH enabled us to characterize this marker as a der(10)t(6;10)(6qter → 6q23.3::10p11.1 → 10p11.21)dn. As far as we know, this is the first diagnosed case of PWLS associated with a complex sSMC, involving a 30.9 Mb gain in the 6q16.3q23.3 region and a 3.5 Mb gain in the 10p11.21p11.1 region. Several genes have been mapped to the 6q region including the TCBA1 gene, which is associated with developmental delay and recurrent infections, the ENPP1 gene, associated with insulin resistance and susceptibility to obesity and the BMIQ3 gene, associated with body mass index (BMI). No OMIM gene was found in the smallest 10p11.21p11.1 region.
We suggest that the duplicated chromosome segment 6q16.3q23.3 may be responsible for the phenotype of our case and may also be a candidate locus of PWLS.
Prader-Willi syndrome (PWS) is characterized by hypotonia during the neonatal stage and in childhood, accompanied by delayed neuropsychomotor development . Overeating, obesity and mental deficiency arise later on. In addition to obesity, Prader-Willi syndrome includes several other endocrine disorders, such as hypothyroidism, growth hormone deficiency, and hypogonadotropic hypogonadism . PWS is caused by a lack of expression of genes located on paternal chromosome 15q11q13. This lack of gene expression may be due to a deletion in this chromosomal segment, to maternal uniparental disomy of chromosome 15, or to a defect in the imprinting centre on 15q11–15q13, or rarely with small supernumerary marker chromosomes 15 (sSMC) . Small supernumerary marker chromosomes (sSMC) are structurally abnormal chromosomes, generally equal in size to or smaller than a chromosome 20 of the same metaphase spread, that cannot be characterized by conventional banding cytogenetics . sSMC can have different shapes (ring-, centric minute- and inverted duplication-shaped), and in most cases consist of pericentric chromosomal material . They can originate from any part of human chromosomes to form neocentromeres . sSMC are found in 0.043 % of new-borns and in 0.433 % of cases with intellectual disability . A number of other conditions associate obesity and developmental disability. These include UPD14, Cohen syndrome, Bardet-Biedl syndrome, Alstrom syndrome, duplications of 3p25.3–p26.2 and of Xq27.2-ter and deletions 1p36, 6q16 (SIM1), and 10q26 . A recent study by array-CGH in 100 children with syndromic obesity showed new candidate genes (PLIN2, CDH13, CNTNAP2, CPPED1, NDUFA4, PTGS2 and SOCS6) and 22 % of patients with pathogenic or potentially pathogenic CNVs were identified .
We report a boy with PWLS associated with a small supernumerary marker chromosome (sSMC). This is the first case of an sSMC involving chromosome 6 and 10 and was characterized as der(10)t(6;10)(6qter → 6q23.3::10p11.1 → 10p11.21)dn. To the best of our knowledge, this is the first PWLS which could be due to a complex sSMC.
The patient, a male, was born to healthy, non-consanguineous parents and has 2 sisters. The heights of the father and mother are 174 and 156 cm, respectively. The patient was born at full term; his birth weight was 3610 g, length 52.5 cm, head circumference 35 cm. Several respiratory tract infections were treated during his first years of life and saturnism was diagnosed at 5 years old, with no need for treatment. The patient had normal psychomotor acquisition (walked at 16 months), developmental delay with school retardation and speech articulation defects. At 15.5 years old (Fig. 1a), the patient was 145.4 cm tall (−3.8SD), 55.3 kg in weight (BMI = 26.6 kg/m2 = +2.8SD: overweight according to WHO criteria ) suffered from intellectual deficiency and could neither read nor write. He had central obesity, small hands and feet (Fig. 1b, c), short stature, pubertal delay (small penis and testes), lower limb livedo, café-au-lait spots on his neck and the facial features of Prader-Willi syndrome. These observations were compatible with the Prader-Willi-like phenotype [6, 9]. Bioassays showed isolated GH deficiency with low IGF-I concentrations with no evidence of hypothalamic-pituitary disease with normal MRI.
Blood samples of the patient and his parents were drawn after informed consent had been obtained. Chromosome analysis was performed on 72-h lymphocyte cultures according to standard techniques . Preparations were GTG and RHG banded by standard procedures. Fluorescence in situ hybridization (FISH) was carried out using octochrome cytocell® according to the manufacturer’s instructions (Cytocell Ltd, Cambridge, United Kingdom). This kit combines an 8-square multiprobe device and the whole chromosome painting probe (labelled in 3 different colours) to allow all 24 chromosomes to be identified on a single slide. Array-CGH analysis was performed according to the Agilent protocol with minor protocol modifications using Agilent 4x180K .
Conventional cytogenetic analysis on cultured T-lymphocytes revealed a male karyotype with a small supernumerary marker chromosome in 32 % of the cells analysed: mos 47, XY,+mar/46,XY (Fig. 2). Parental karyotypes from peripheral blood lymphocytes were both normal, indicating a de novo origin of the sSMC. The karyotype after conventional cytogenetic analysis and FISH (whole painting probe) can be described as: mos 47,XY,+mar/46,XY.ish neo(6)(wcp6+, D6Z1-, tel6p-, tel6q-)dn. Array-CGH analysis confirmed the duplicated region of chromosome 6 (Fig. 3a): 6q16.3q23.3 (102,474,305-133,386,766) of 30.9 Mb that included the 153 genes previously observed in FISH and showed a duplicated pericentromeric region 10p11.21p11.1 (35,490,990-39,076,732) (GRCh37/hg19) of 3.5 Mb that included 7 genes (Fig. 3b). The duplicated region of chromosome 10 was confirmed by another centromere FISH of chromosome 10 (Fig. 4). The resulting karyotype associated with array-CGH analysis can be described as 47,XY,+ der(10)t(6;10)(6qter → 6q23.3::10p11.1 → 10p11.21)dn arr[hg19]6q16.3q23.3(102,474,305-133,836,766)×2 ~ 3,10p11.21p11.1(35,490,990-39,076,732)×2 ~ 3. Array-CGH mosaicism of chromosome 10 and chromosome 6 was estimated at about 25.0 % (log2 ratio: 0.14). The mosaicism rate found with array-CGH analysis was similar to that found with karyotyping. Maternal uniparental disomy of chromosome 15 was ruled out (data not shown).
To the best of our knowledge, this is the first report of a patient with PWLS associated with a complex sSMC, which involved chromosome 6 and 10 at breakpoints of 6q16.3q23.3 and 10p11.21p11.1, respectively. Complex small supernumerary marker chromosomes (sSMC) are a subgroup of sSMC derived from more than one chromosome . The Liehr sSMC database  has collected approximately 412 cases of complex sSMC from the literature, which represent 8.4 % of all sSMC cases . The majority of complex sSMC cases are der(22)t(11;22)(q23;q11.2) or Emanuel syndrome cases (339/412 cases; 82 %) and present generally in banding cytogenetics as centric minutes . Among the 73 complex sSMC described by Liehr T. excluding Emanuel syndrome, 64 % were inherited from a balanced translocation in one parent (83 % maternally derived)  and 10 % were in mosaic. All of the human chromosomes, except chromosome 10, have already been shown to be involved in complex sSMC .
To investigate whether the duplicated 6q16.3q23.3 and 10p11.21p11.1 regions could play a role in PWL syndrome, all cases with comparable chromosome 6q and 10p duplications documented in PubMed, the sSMC Liehr database  and DECIPHER  were reviewed. Duplications of the 6q16.3q23.3 region are rare and no similar cases with sSMC comprising the 6q16.3q23.3 region have ever been described in the literature [12, 14]. Two cases with 6q16.3q23.3 duplications are reported in the DECIPHER database  (available from http://decipher.sanger.ac.uk and via email from email@example.com.) with the phenotype: case 4145 (7 Mb duplication) with brachycephaly, epicanthus, intellectual disability, intrauterine growth retardation, muscular hypotonia and ptosis; case 2068365 (2.3 Mb duplication) with hydrocephalus, macrocephaly and parietal foramina. Three cases with 6q21q23 duplications were described only at the cytogenetic level and associated with developmental delay, congenital hearts defects, depressed nasal bridge and epicanthal folds [15, 16] and two cases of 6q21q22.1 in a mother and her daughter showed similar phenotypes (cognitive difficulties, obesity, essential tremor) and café-au-lait spots in the daughter . Regarding other regions of 6q chromosome, trisomy 6qter has also been associated with mental retardation and obesity starting from childhood [18, 19], but cases of neocentric sSMC (6q) phenotypes show no similarity to ours [12, 20, 21]. Our patient’s complex sSMC involves chromosome 10 too and it is, to the best of our knowledge, the first report of a complex sSMC involving chromosome 10 and characterized by array-CGH. All human chromosomes have already been included in a complex sSMC except for chromosome 10. The pericentromeric region of chromosome 10 is known to comprise many copy number variations and other repetitive elements . In our case, the OMIM gene map search  for the duplicated 10p11.21p11.1 region revealed no disease-causing genes.
A total of 60 CNVs have been found in 100 patients with syndromic obesity in a recent study  using array-CGH and can be classified into three groups: the first was considered clinically relevant for syndromic obesity (n = 14), the second potentially relevant (n = 17) and the third probably benign (n = 29). The second group with potentially clinically relevant CNVs (inherited from one parent with an abnormal phenotype) contained genes of particular interest involved in insulin or adiponectin receptor and peroxisomal acid metabolism: SOC6, PLIN2, CDH13, CNTNAP2, SOX3 and ACOXL.
The OMIM gene map search  of the duplicated 6q16.3q23.3 region revealed more than 150 genes including TCBA1, BMIQ3 and ENPP1 genes. Two balanced translocations showed that the TCBA1 (NKAIN2; Na+/K+ transporting ATPase-Interacting Protein 2) gene was truncated in 1 patient with a severe neurological phenotype (epileptic encephalopathy with spastic tetraparesis and severe psychomotor retardation, microcephaly, hand dysmorphism and hypogonadism with micropenis and cryptorchidism), and a second patient with developmental delay and recurrent infections [24, 25]. These two de novo translocations provide evidence that constitutional inactivation (haploinsufficiency) of the TCBA1 gene causes developmental delay and a distinct phenotype. BMIQ3 was linked with body mass index (BMI) using a genome-wide linkage analysis  using polymorphic markers and LOD scores. In the same way, ENPP1 was associated with insulin resistance and susceptibility to obesity . Moreover, Prader-Willi-like syndrome with growth hormone deficit has been described with 6q16.1–q21deletions [28, 29] and associated with Single-minded 1 gene (SIM1) at 6q16.2  and/or POU3F2 (BRN2) at 6q16.1 . However the SIM1 and POU3F2 genes were not included in the duplicated 6q16.3q23.2 region of our patient.
According to these data and a review of the literature, our patient’s phenotype seems to be related to the euchromatin of chromosome 6 rather than chromosome 10. The duplicated 6q16.3q23.3 may be a candidate locus of PWLS with TCBA1 as the candidate gene for mental retardation and BMIQ3 and ENPP1 implicated in the susceptibility to obesity. This case illustrates the importance of array-CGH to characterize more precisely sSMC not elucidated by FISH, and suggests that all neocentromere markers detected by karyotype must by analysed by array-CGH.
Written informed consent was obtained from the patient’s parents for publication and accompanying images of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet Med. 2012;14(1):10–26.
Liehr T, Claussen U, Starke H. Small supernumerary marker chromosomes (sSMC) in humans. Cytogenet Genome Res. 2004;107(1–2):55–67.
Liehr T, Cirkovic S, Lalic T, Guc-Scekic M, de Almeida C, Weimer J, et al. Complex small supernumerary marker chromosomes - an update. Mol Cytogenet. 2013;6(1):46.
Liehr T, Utine GE, Trautmann U, Rauch A, Kuechler A, Pietrzak J, et al. Neocentric small supernumerary marker chromosomes (sSMC)–three more cases and review of the literature. Cytogenet Genome Res. 2007;118(1):31–7.
Liehr T, Weise A. Frequency of small supernumerary marker chromosomes in prenatal, newborn, developmentally retarded and infertility diagnostics. Int J Mol Med. 2007;19(5):719–31.
Rocha CF, Paiva CLA. Prader-Willi-like phenotypes: a systematic review of their chromosomal abnormalities. Genet Mol Res. 2014;13(1):2290–8.
Vuillaume ML, Naudion S, Banneau G, Diene G, Cartault A, Cailley D, et al. New candidate loci identified by array-CGH in a cohort of 100 children presenting with syndromic obesity. Am J Med Genet A. 2014;164A(8):1965–75.
WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Genève: Organisation mondiale de la Santé; 2006. p. 312.
Cassidy SB, Driscoll DJ. Prader-Willi syndrome. Eur J Hum Genet. 2009;17(1):3–13.
Verma RS, Babu A. Human chromosomes – Manual of basic technologies. 4th ed. New York: Perga-mon Press; 1998. p. 6–71.
Marle N, Martinet D, Aboura A, Joly-Helas G, Andrieux J, Flori E, et al. Molecular characterization of 39 de novo sSMC: contribution to prognosis and genetic counselling, a prospective study. Clin Genet. 2014;85(3):233–44.
Liehr T. Small supernumerary marker chromosomes. 2015. http://ssmc-tl.com/sSMC.html [accessed 18/05/2015].
Huang B, Pearle P, Rauen KA, Cotter PD. Supernumerary marker chromosomes derived from chromosome 6: cytogenetic, molecular cytogenetic, and array CGH characterization. Am J Med Genet A. 2012;158A(7):1568–73.
Zneimer SM, Ziel B, Bachman R. Partial trisomy of chromosome 6q: an interstitial duplication of the long arm. Am J Med Genet. 1998;80(2):133–5.
Pratt VM, Roberson JR, Weiss L, Van Dyke DL. Duplication 6q21q23 in two unrelated patients. Am J Med Genet. 1998;80(2):112–4.
Pazooki M, Lebbar A, Roubergues A, Baverel F, Letessier D, Dupont JM. Pure familial 6q21q22.1 duplication in two generations. Eur J Med Genet. 2007;50(1):60–5.
Smith A, Jauch A, Slater H, Robson L, Sandanam T. Syndromal obesity due to paternal duplication 6(q24.3-q27). Am J Med Genet. 1999;84(2):125–31.
D’Angelo CS, Kohl I, Varela MC, de Castro CI, Kim CA, Bertola DR, et al. Obesity with associated developmental delay and/or learning disability in patients exhibiting additional features: report of novel pathogenic copy number variants. Am J Med Genet A. 2013;161A(3):479–86.
Sala E, Crosti F, Villa N, Oldrini A, Lalatta F, Gandolfi P, et al. First report of a supernumerary marker chromosome 6. Chromosome Res. 2005;13 suppl. 1:131. 7.26-P.
Qin N, Bartley J, Wang JC, Warburton PE. A neocentromere derived from a supernumerary marker deleted from the long arm of chromosome 6. Cytogenet Genome Res. 2007;119(1–2):154–7.
Jackson MS, Rocchi M, Thompson G, Hearn T, Crosier M, Guy J, et al. Sequences flanking the centromere of human chromosome 10 are a complex patchwork of arm-specific sequences, stable duplications and unstable sequences with homologies to telomeric and other centromeric locations. Hum Mol Genet. 1999;8(2):205–15.
OMIM geneMap. http://www.omim.org/search/advanced/geneMap.
Bocciardi R, Giorda R, Marigo V, Zordan P, Montanaro D, Gimelli S, et al. Molecular characterization of a t(2;6) balanced translocation that is associated with a complex phenotype and leads to truncation of the TCBA1 gene. Hum Mutat. 2005;26(5):426–36.
Yue Y, Stout K, Grossmann B, Zechner U, Brinckmann A, White C, et al. Disruption of TCBA1 associated with a de novo t(1;6)(q32.2;q22.3) presenting in a child with developmental delay and recurrent infections. J Med Genet. 2006;43(2):143–7.
Atwood LD, Heard-Costa NL, Cupples LA, Jaquish CE, Wilson PWF, D’Agostino RB. Genomewide linkage analysis of body mass index across 28 years of the Framingham heart study. Am J Hum Genet. 2002;71(5):1044–50.
Pizzuti A, Frittitta L, Argiolas A, Baratta R, Goldfine ID, Bozzali M, et al. A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes. 1999;48(9):1881–4.
Izumi K, Housam R, Kapadia C, Stallings VA, Medne L, Shaikh TH, et al. Endocrine phenotype of 6q16.1–q21 deletion involving SIM1 and Prader–Willi syndrome-like features. Am J Med Genet A. 2013;161(12):3137–43.
Villa A, Urioste M, Bofarull JM, Martínez-Frías ML. De novo interstitial deletion q16.2q21 on chromosome 6. Am J Med Genet. 1995;55(3):379–83.
Khattabi LE, Guimiot F, Pipiras E, Andrieux J, Baumann C, Bouquillon S, et al. Incomplete penetrance and phenotypic variability of 6q16 deletions including SIM1. Eur J Hum Genet EJHG. 2014. doi: 10.1038/ejhg.2014.230.
We thank Philip Bastable for the English revision of this manuscript. Thanks to french ministry health for the grant of PHRC 2012 COMPASS.
The authors declare that they have no competing interests.
All authors have made substantial contributions to conception and design, acquisition of data, analysis and interpretation of data. All authors have been involved in drafting the manuscript and revising it critically for important intellectual content. All authors read and approved the final manuscript.
About this article
Cite this article
Desch, L., Marle, N., Mosca-Boidron, A. et al. 6q16.3q23.3 duplication associated with Prader-Willi-like syndrome. Mol Cytogenet 8, 42 (2015). https://doi.org/10.1186/s13039-015-0151-6
- Complex sSMC, Array-CGH
- Prader-Willi-like syndrome, 6q16.3q23.3